Mary L Gemignani
Overview
Explore the profile of Mary L Gemignani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
1255
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Myers S, Gilliland J, Goldfarb S, Gemignani M
J Adolesc Young Adult Oncol
. 2024 Nov;
PMID: 39527023
In this focus group study of 11 women younger than 45 years of age treated at Memorial Sloan Kettering Cancer Center (New York, NY, USA) between March 2020 and April...
2.
Myers S, Aviki E, Sevilimedu V, Thom B, Gemignani M
Ann Surg Oncol
. 2024 Aug;
31(12):8112-8113.
PMID: 39172300
No abstract available.
3.
Myers S, Aviki E, Sevilimedu V, Thom B, Gemignani M
Ann Surg Oncol
. 2024 Jul;
31(12):8040-8047.
PMID: 39078600
Introduction: Financial toxicity negatively affects clinical outcomes in breast cancer. Underrepresented demographics may be at higher risk for financial toxicity. We characterized disparities on the basis of age and other...
4.
Jones V, Nelson J, Sevilimedu V, Le T, Allen Jr R, Mehrara B, et al.
Ann Surg Oncol
. 2024 Jul;
31(10):6795-6803.
PMID: 38990221
Background: Mastectomy skin flap necrosis (SFN) is common following nipple-sparing mastectomy (NSM), but studies on its quality-of-life (QOL) impact are limited. We examined patient-reported QOL and satisfaction after NSM with/without...
5.
Zhang J, Dos Anjos C, Sevilimedu V, Crown A, Amoroso K, Pilewskie M, et al.
Ann Surg Oncol
. 2023 Sep;
30(12):6990-6999.
PMID: 37661222
Background: The impact of ATM, CHEK2, and PALB2, the three most prevalent moderate-risk breast cancer genes, on surgical decision making is not well known. Methods: Our retrospective study included patients...
6.
Pak L, Matar-Ujvary R, Verdial F, Haglich K, Sevilimedu V, Nelson J, et al.
Ann Surg Oncol
. 2023 Aug;
30(12):7091-7098.
PMID: 37556008
Introduction: Oncoplastic breast surgery (OBS) combines plastic surgery techniques with conventional breast-conserving surgery (BCS) and expands BCS eligibility. Limited data are available on patient-reported outcomes (PROs) after OBS. Here we...
7.
Matar-Ujvary R, Haglich K, Flanagan M, Fuzesi S, Sevilimedu V, Nelson J, et al.
Ann Surg Oncol
. 2023 Jun;
30(9):5341-5349.
PMID: 37306849
Background: Approximately 14% of women undergoing breast-conserving surgery (BCS) require re-excision to achieve negative margins following the Society of Surgical Oncology (SSO) and American Society for Radiation Oncology (ASTRO) margin...
8.
Moo T, Nelson J, Sevilimedu V, Charyn J, Le T, Allen R, et al.
Br J Surg
. 2023 May;
110(7):831-838.
PMID: 37178195
Background: Nipple-sparing mastectomy is associated with a higher risk of mastectomy skin-flap necrosis than conventional skin-sparing mastectomy. There are limited prospective data examining modifiable intraoperative factors that contribute to skin-flap...
9.
Crown A, McCartan D, Curry M, Patil S, Kamer S, Goldfarb S, et al.
Breast Cancer Res Treat
. 2023 Jan;
198(2):283-294.
PMID: 36662395
Purpose: Pregnancy-associated breast cancer (PABC) comprises breast cancer diagnosed during the gestational period or within 12 months postpartum. While the incidence of PABC appears to be increasing, data regarding prognosis...
10.
Mamtani A, Grabenstetter A, Sevilimedu V, Morrow M, Gemignani M
Breast Cancer Res Treat
. 2022 Nov;
197(2):417-423.
PMID: 36394689
Purpose: Invasive lobular breast cancers (ILCs) respond poorly to neoadjuvant chemotherapy (NAC). The degree of benefit of NAC among non-classic ILC (NC-ILC) variants compared with classic ILCs (C-ILCs) is unknown....